Buy or build: Strategies to meet demand for vaccine and viral vector production [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
Since that golden era, however, low profit margins and greater regulatory scrutiny caused the market to contract. North America, for example, has seen a significant decline in the number of vaccine manufacturers over recent years. But the landscape is changing again. Ground-breaking developments in cell and gene therapy are seeing the application of viral vectors as an important platform for vaccines and therapeutic applications. There is now a shift towards high-value yet low-volume vaccines, presenting a new set of manufacturing challenges. These new trends, along with the dynamism displayed in last year's high-speed race for the Covid-19 vaccine (which also led to the first ever approvals for mRNA vaccines), have reinvigorated a stagnating industry. A recent report from Allied Market Research forecasts the vaccine market to reach $55.15bn by 2027, registering a CAGR of 6.6% from 2020. Viral vector and therapeutic vaccines Viral vector-based vaccines will see particularly fa
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock [Yahoo! Finance]Yahoo! Finance
- AstraZeneca & Aptamer partner to bolster targeted siRNA therapies [Yahoo! Finance]Yahoo! Finance
- AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC [Yahoo! Finance]Yahoo! Finance
- AstraZeneca's Tagrisso plus chemotherapy wins EU approval for NSCLC [Yahoo! Finance]Yahoo! Finance
- Innovent sells its share in CAR T-cell therapy to IASO Bio for 18% equity [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 7/1/24 - Form 6-K
- 7/1/24 - Form 6-K
- 6/26/24 - Form 11-K
- AZN's page on the SEC website